Commission Implementing Regulation (EU) 2022/1107 of 4 July 2022 laying down common specifications for certain class D in vitro diagnostic medical devices in accordance with Regulation (EU) 2017/746 of the European Parliament and of the Council (Text with EEA relevance)
Articolo 1Common specifications
In vigore · versione del 25 lug 2022
This Regulation lays down common specifications for certain class D in vitro diagnostic medical devices in respect of the requirements regarding the performance characteristics set out in Section 9.1, points (a) and (b), Section 9.3 and Section 9.4, point (a), of Annex I to Regulation (EU) 2017/746.
Annex I lays down common specifications for devices covered by Annexes II to XIII, as specified in that Annex.
Annex II lays down common specifications for devices intended for detection of blood group antigens in the ABO, Rh, Kell, Duffy and Kidd blood group systems.
Annex III lays down common specifications for devices intended for detection or quantification of markers of human immunodeficiency virus (HIV) infection.
Annex IV lays down common specifications for devices intended for detection or quantification of markers of human T-cell lymphotropic virus (HTLV) infection.
Annex V lays down common specifications for devices intended for detection or quantification of markers of hepatitis C virus (HCV) infection.
Annex VI lays down common specifications for devices intended for detection or quantification of markers of hepatitis B virus (HBV) infection.
Annex VII lays down common specifications for devices intended for detection or quantification of markers of hepatitis D virus (HDV) infection.
Annex VIII lays down common specifications for devices intended for detection of markers of variant Creutzfeldt-Jakob disease (vCJD).
Annex IX lays down common specifications for devices intended for detection or quantification of markers of cytomegalovirus (CMV) infection.
Annex X lays down common specifications for devices intended for detection or quantification of markers of Epstein-Barr virus infection (EBV).
Annex XI lays down common specifications for devices intended for detection of markers of Treponema pallidum infection.
Annex XII lays down common specifications for devices intended for detection or quantification of markers of Trypanosoma cruzi infection.
Annex XIII lays down common specifications for devices intended for detection or quantification of markers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.